🇺🇸 FDA
Company

Nurix

Nurix Therapeutics

NRIX pharma USA

Quick answer

Nurix is a pharma company (NRIX) headquartered in BRISBANE, CA, USA with 7 tracked pipeline programs.

Pipeline (7)

project

NX-5948

B-cell Lymphoma

Phase 3 · small_molecule · active

2 trials project

NX-5948

Chronic Lymphocytic Leukemia (CLL)

Phase 2 · small_molecule · active

2 trials project

Drug Product De-TIL-0255

Platinum-resistant Ovarian Cancer

Phase 1 · mab · terminated

1 trials project

IP

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

NX-1607

Ovarian Cancer, Epithelial

Phase 1 · small_molecule · active

1 trials project

NX-2127

Chronic Lymphocytic Leukemia (CLL)

Phase 1 · small_molecule · active

1 trials project

NX-5948

Healthy Volunteer

Phase 1 · small_molecule · active

2 trials

Patents (8)

patent

US 12377106

Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12234230

Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12121540

CBL inhibitors and compositions for use in adoptive cell therapy

Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12091426

Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses t

Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12049471

Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof

Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12016860

Combination therapies with Cbl-b inhibitor compounds

Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11951133

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11866442

Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)